SCHEMBL2569796

SCHEMBL2569796

CCCC=CCCCCC=CCCCCC(=O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.80
PPARD Q03181 6/20 0.80
PPARA Q07869 6/20 0.80
F7 P08709 6/20 0.80
F3 P13726 6/20 0.80
TERT O14746 3/20 0.80
PTPN1 P18031 3/20 0.80
HSD17B10 Q99714 3/20 0.80
FABP4 P15090 3/20 0.80
PTGS1 P23219 3/20 0.80
MAPT P10636 2/20 0.80
BLM P54132 2/20 0.80
LMNA P02545 2/20 0.80
ALOX15 P16050 2/20 0.80
DUSP3 P51452 2/20 0.80
CYP19A1 P11511 2/20 0.80
NR4A2 P43354 2/20 0.80
SIRT6 Q8N6T7 2/20 0.80
PTPN7 P35236 2/20 0.80
TDP1 Q9NUW8 2/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22320200 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL28959617 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL414679 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL91182 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2569791 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2569794 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL30641896 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL414678 1.00 PPARG (0.80) PPARGPPARDPPARAF7F3
SCHEMBL2690850 0.98 PPARG (0.84) PPARGPPARDPPARAF7F3
SCHEMBL2721190 0.98 PPARG (0.84) PPARGPPARDPPARAF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125614-A1 IONIZABLE CATIONIC LIPIDS AKAGERA MEDICINES, INC. (US) 2026-05-07 US disclosed
US-12606773-B2 Ionizable cationic lipids AKAGERA MEDICINES, INC. (US) 2026-04-21 US disclosed
US-20260055335-A1 IONIZABLE CATIONIC LIPID COMPOUNDS AKAGERA MEDICINES, INC. (US) 2026-02-26 US disclosed
US-12331264-B2 Lipid nanoparticles for delivery of nucleic acids and methods of use thereof AKAGERA MEDICINES, INC. (US) 2025-06-17 US disclosed
CN-113661165-B Pesticidally active diazine-amide compounds 先正达农作物保护股份公司 2025-05-23 CN disclosed
CN-115210218-B Pesticidally active cyclic amine compounds 先正达农作物保护股份公司 2025-05-16 CN disclosed
CN-114630825-B Condensed with pesticidal activity bicyclic heteroaromatic compounds 先正达农作物保护股份公司 2025-05-16 CN disclosed
CN-113597424-B Pesticidal active azole amide compounds 先正达农作物保护股份公司 2025-04-18 CN disclosed
CN-115003666-B Condensed derivatives of pesticidal activity Cyclic heteroaromatic amino compounds 先正达农作物保护股份公司 2025-03-21 CN disclosed
CN-114401963-B Pesticidally active cyclic amine compounds 先正达农作物保护股份公司 2025-03-14 CN disclosed
US-20220162521-A1 IONIZABLE CATIONIC LIPIDS AKAGERA MEDICINES, INC. 2022-05-26 US disclosed
CN-114401963-A Pesticidally active cyclic amine compounds 先正达农作物保护股份公司 2022-04-26 CN disclosed
CN-114340374-A Sowing device and method for treating seeds during planting 先正达参股股份有限公司 2022-04-12 CN disclosed
CN-114341142-A Strigolactone derivatives as plant growth regulator compounds 先正达农作物保护股份公司 2022-04-12 CN disclosed
CN-114269143-A High precision greenhouse treatment of seeds and seedlings 先正达参股股份有限公司 2022-04-01 CN disclosed
CN-114269732-A Pesticidally active pyrazine-amide compounds 先正达农作物保护股份公司 2022-04-01 CN disclosed
CN-114072384-A Microbicidal picolinamide derivatives 先正达农作物保护股份公司 2022-02-18 CN disclosed
WO-2015128428-A1 PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL BASF SE (DE) 2015-09-03 WO disclosed
EP-2384111-A1 PHEROMONE DISPENSER BASF SE (DE) 2011-11-09 EP disclosed
WO-2010076316-A1 PHEROMONE DISPENSER BASF SE (DE) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125614-A1 IONIZABLE CATIONIC LIPIDS CPT2, NPC1L1, PNPLA2 PPARG 1698/4885PPARD 961/4885PPARA 810/4885
US-20220162521-A1 IONIZABLE CATIONIC LIPIDS PHOSPHO1, LIPA, ABHD16A PPARG 1040/4885PPARD 948/4885PPARA 966/4885
US-12606773-B2 Ionizable cationic lipids NPC1L1, MCOLN1, SLC22A4 PPARG 3314/4885PPARD 2423/4885PPARA 2217/4885
US-20260055335-A1 IONIZABLE CATIONIC LIPID COMPOUNDS CD4, LDLR, CD2BP2 PPARG 1249/4885PPARD 838/4885PPARA 730/4885
US-12331264-B2 Lipid nanoparticles for delivery of nucleic acids and methods of use thereof ASGR1, LDLR, CD2BP2 PPARG 1873/4885PPARD 1929/4885PPARA 1234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.